Capital International Sarl Catalent, Inc. Transaction History

Capital International Sarl

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $27,227 - $30,923	616 Added 13.19%	5,285 $240,000
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $127,822 - $269,847	-4,012 Reduced 46.22%	4,669 $202,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $394,464 - $644,651	8,681 New	8,681 $570,000
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $711,680 - $827,744	-5,952 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $32,751 - $42,705	300 Added 5.31%	5,952 $792,000
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $122,916 - $141,720	1,225 Added 27.67%	5,652 $611,000
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $34,716 - $42,842	342 Added 8.37%	4,427 $466,000
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $350,819 - $430,395	4,085 New	4,085 $425,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

Stay updated on Capital International Sarl with notifications on news.